Cargando…

Application of nano‐radiosensitizers in combination cancer therapy

Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation‐induced killing, while simultaneously reducing the potentially damaging effect on the cellular structur...

Descripción completa

Detalles Bibliográficos
Autores principales: Varzandeh, Mohammad, Sabouri, Leila, Mansouri, Vahid, Gharibshahian, Maliheh, Beheshtizadeh, Nima, Hamblin, Michael R., Rezaei, Nima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189501/
https://www.ncbi.nlm.nih.gov/pubmed/37206240
http://dx.doi.org/10.1002/btm2.10498
_version_ 1785043102259478528
author Varzandeh, Mohammad
Sabouri, Leila
Mansouri, Vahid
Gharibshahian, Maliheh
Beheshtizadeh, Nima
Hamblin, Michael R.
Rezaei, Nima
author_facet Varzandeh, Mohammad
Sabouri, Leila
Mansouri, Vahid
Gharibshahian, Maliheh
Beheshtizadeh, Nima
Hamblin, Michael R.
Rezaei, Nima
author_sort Varzandeh, Mohammad
collection PubMed
description Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation‐induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano‐radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects.
format Online
Article
Text
id pubmed-10189501
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-101895012023-05-18 Application of nano‐radiosensitizers in combination cancer therapy Varzandeh, Mohammad Sabouri, Leila Mansouri, Vahid Gharibshahian, Maliheh Beheshtizadeh, Nima Hamblin, Michael R. Rezaei, Nima Bioeng Transl Med Review Articles Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation‐induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano‐radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects. John Wiley & Sons, Inc. 2023-02-10 /pmc/articles/PMC10189501/ /pubmed/37206240 http://dx.doi.org/10.1002/btm2.10498 Text en © 2023 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Varzandeh, Mohammad
Sabouri, Leila
Mansouri, Vahid
Gharibshahian, Maliheh
Beheshtizadeh, Nima
Hamblin, Michael R.
Rezaei, Nima
Application of nano‐radiosensitizers in combination cancer therapy
title Application of nano‐radiosensitizers in combination cancer therapy
title_full Application of nano‐radiosensitizers in combination cancer therapy
title_fullStr Application of nano‐radiosensitizers in combination cancer therapy
title_full_unstemmed Application of nano‐radiosensitizers in combination cancer therapy
title_short Application of nano‐radiosensitizers in combination cancer therapy
title_sort application of nano‐radiosensitizers in combination cancer therapy
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189501/
https://www.ncbi.nlm.nih.gov/pubmed/37206240
http://dx.doi.org/10.1002/btm2.10498
work_keys_str_mv AT varzandehmohammad applicationofnanoradiosensitizersincombinationcancertherapy
AT sabourileila applicationofnanoradiosensitizersincombinationcancertherapy
AT mansourivahid applicationofnanoradiosensitizersincombinationcancertherapy
AT gharibshahianmaliheh applicationofnanoradiosensitizersincombinationcancertherapy
AT beheshtizadehnima applicationofnanoradiosensitizersincombinationcancertherapy
AT hamblinmichaelr applicationofnanoradiosensitizersincombinationcancertherapy
AT rezaeinima applicationofnanoradiosensitizersincombinationcancertherapy